No Data
Is Takeda Pharmaceutical Co. (TAK) a Great Value Stock Right Now?
Vatroslav Mateljic Appointed General Manager Of Takeda Canada
Protagonist Therapeutics' Two Investigational Candidates Target Over $10B Market, Bullish Analyst Opines
Enliven Therapeutics' Leukemia Candidate Could Challenge Pfizer, AstraZeneca In Broader Target Market: Analyst
Multiple Myeloma Market Report and Company Analysis, 2024-2032 Featuring Novartis, AbbVie., Sanofi, Johnson & Johnson, Baxter International, Pfizer, Takeda Pharmaceutical, and Bristol-Myers Squibb
CORUNDUM SYSTEMS BIOLOGY APPOINTS JESSICA SCHNEIDER AS CHIEF SCIENTIFIC OFFICER